UW News

medicine & pharmaceuticals


July 22, 2022

Novel HIV combination therapies could prevent viral escape and rebound

New research by scientists at the University of Washington, the Max Planck Institute for Dynamics and Self-Organization and the University of Cologne indicates that carefully designed cocktails of broadly neutralizing antibodies could help treat HIV while minimizing the risk of the virus evolving to “escape” treatment.


September 3, 2014

Health Sciences News Digest

Pharmacy teaching Ebola

Latest news from the UW Health Sciences: Comparative genomes, open notes, teaching Ebola, depression in women


May 6, 2014

Health sciences digest: Drug pricing uproar, antioxidant dangers

The latest news from the UW Health Sciences and UW Medicine:   What price for a cure? The economics of drug pricing The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States.  Purchasers appear to be pushing back and saying, “No.”…


March 19, 2014

Anti-anxiety drug ameliorates autistic behaviors in mice

autistics mice

Increasing cell signals that put the brake on excitatory brain cells reduces repetitive behaviors and learning problems and improves social interactions in a mouse model of autism. This was achieved with a low dose of benzodiazipine, a common anti-anxiety, anti-seizure medication.


May 22, 2013

Practicing medicine pharma-free in a drug rep-filled world

A rural family medicine group is an example for other community physicians seeking to wean themselves from pharmaceutical industry influence.


January 29, 2013

Beer’s bitter compounds could help brew new medicines

A humulone molecule is superimposed on a hops vine and a glass of beer.

A UW researcher has determined the precise configuration of substances derived from hops that give beer its distinctive flavor, a finding that could lead to important new pharmaceuticals.